Image

ISRO Successfully Tests Upgraded SSLV Third Stage

Jan 01, 2026

ISRO Clears Upgraded SSLV Stage for Future Missions

The Indian Space Research Organisation (ISRO) has achieved a significant milestone in its small satellite launch programme with the successful ground test of the upgraded third stage (SS3) of the Small Satellite Launch Vehicle (SSLV). Conducted on December 30, 2025, the test validates critical design upgrades and clears the stage for induction into upcoming SSLV missions, reinforcing India’s launch-on-demand capability.

Month: 

Category: 

Indian Army Performs India’s First 3D Flex Aqueous Angiography Surgery

Jan 01, 2026

Landmark Ophthalmic Achievement by the Indian Army

In a significant breakthrough for eye care in India, the Indian Army has successfully conducted the country’s first 3D Flex Aqueous Angiography with iStent implantation. The pioneering glaucoma procedure was performed at the Army Hospital (Research & Referral), Delhi Cantt, placing the Armed Forces Medical Services at the forefront of advanced ophthalmic innovation.

Month: 

Category: 

Centre Launches ₹4,531-Crore Market Access Support Scheme

Jan 01, 2026

New Market Access Support Scheme Rolled Out

The Union government has launched a new Market Access Support (MAS) intervention with a total outlay of ₹4,531 crore, aimed at strengthening India’s export ecosystem over the next six years. The initiative is designed to enhance India’s presence in global markets by facilitating structured, outcome-driven engagement between Indian exporters and overseas buyers.

Month: 

Category: 

Health Ministry Bans High-Dose Oral Nimesulide Formulations

Jan 01, 2026

Centre Prohibits Oral Nimesulide Above 100 mg

In a decisive move to strengthen pharmaceutical safety, the Union Health Ministry has banned all oral formulations of Nimesulide exceeding 100 mg, with effect from December 31, 2025. The prohibition follows scientific evaluation of potential health risks and reflects a precautionary regulatory approach amid the availability of safer alternatives for pain and fever management.

Month: 

Category: 

Scientists Turn Cancer Drug Resistance into an Immunotherapy Advantage

Jan 01, 2026

Rethinking Cancer Drug Resistance

Cancer treatment often faces a critical setback when tumours stop responding to medicines that initially work well. In advanced and metastatic cancers, tumour cells frequently acquire new genetic mutations that allow them to bypass targeted drugs. This acquired resistance remains one of the biggest barriers to durable cancer control, even with cutting-edge therapies.

Month: 

Category: